601607 上海醫藥
按盤價 
17.810 +0.060 (+0.338%) | 2023/12 - 人民幣(K¥) | 變動 | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | 2019/12 人民幣(K¥) | 2018/12 人民幣(K¥) | ||
| 營業總收入 | 260,295,089 | 12.21% | 215,824,259 | 191,909,156 | 186,565,796 | 159,084,397 | |
| 減：營業總成本 | 253,008,864 | 12.49% | 209,641,475 | 185,559,849 | 180,412,001 | 154,256,560 | |
| 其中:營業成本 | 228,966,947 | 13.63% | 187,281,149 | 165,180,104 | 159,751,670 | 136,521,469 | |
| 財務費用 | 1,485,758 | 13.14% | 1,245,369 | 1,239,584 | 1,258,772 | 1,032,087 | |
| 資產減值損失 | (561,277) | 69.33% | (140,441) | (898,616) | (1,093,122) | (995,517) | |
| 公允價值變動收益 | 404,731 | 85.03% | (206,004) | 116,798 | 122,163 | 15,894 | |
| 投資收益 | (68,123) | -112.78% | 1,811,394 | 976,195 | 653,782 | 1,064,719 | |
| 其中：對聯營企業和合營企業的投資收益 | 129,329 | -75.45% | 789,596 | 1,009,547 | 765,186 | 647,710 | |
| 營業利潤 | 7,667,235 | -14.95% | 8,205,486 | 7,184,388 | 6,213,947 | 5,208,332 | |
| 利潤總額 | 7,054,297 | -19.91% | 8,143,815 | 7,175,483 | 6,262,467 | 5,343,378 | |
| 減：所得稅費用 | 1,887,726 | 3.93% | 1,869,245 | 1,570,219 | 1,431,725 | 887,117 | |
| 淨利潤 | 5,166,570 | -26.11% | 6,274,569 | 5,605,264 | 4,830,742 | 4,456,261 | |
| 減：非控股權益 | 1,398,571 | 1.72% | 1,181,102 | 1,109,047 | 749,748 | 575,198 | |
| 股東淨利潤 | 3,768,000 | -32.92% | 5,093,467 | 4,496,217 | 4,080,994 | 3,881,063 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 1.020 | -36.65% | 1.790 | 1.580 | 1.440 | 1.370 | |
| 每股派息 (元) * | 0.410 | -32.79% | 0.420 | 0.480 | 0.440 | 0.410 | |
| 每股淨資產 (元) * | 18.500 | 2.00% | 17.367 | 15.958 | 14.658 | 13.727 | |
| 審計意見 # | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 25/04/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
